[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"post-operative-complications\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:post-operative-complications":321},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,54,81,119,158,195,232,259,286],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":42,"lastUpdatePostDateStruct":43,"startDateStruct":46,"completionDateStruct":48,"leadSponsor":50,"locationsCount":53},"100640362","swedish-national-parotidectomy-study-snaps-drainless-versus-standard-surgery-100640362",false,"NCT07620184","Swedish National Parotidectomy Study (SNaPs): Drainless Versus Standard Surgery","A Prospective, Randomized, Multicenter Non-Inferiority Trial Evaluating the Safety of Parotidectomy Without Active Surgical Drainage (Svenska Nationella Parotisstudien)","SNaPs","Inclusion Criteria:\n\n* Patients scheduled to undergo partial or superficial parotidectomy without concurrent soft tissue surgery, in cases where a wound drain is traditionally used (extirpation of single adjacent lymph nodes is acceptable).\n* ASA physical status class 1-3.\n* Aged 18 years or older.\n* The patient understands the participant information and is able to make an informed choice.\n\nExclusion Criteria:\n\n* Previous parotid surgery on the same side\n* Tumour with parapharyngeal extension.\n* Ongoing or planned perioperative treatment with tranexamic acid.\n* Ongoing treatment with dual antiplatelet therapy (single agent therapy, such as Aspirin or Clopidogrel, is not an exclusion criterion).\n* Ongoing treatment with anticoagulants (NOAC, Warfarin) at the time of surgery. NOAC must be discontinued at least 24 hours before surgery.\n* Ongoing treatment with low molecular weight heparin in doses higher than: Fragmin 5000 IU\u002Fday, Clexane 40 mg\u002Fday, or Innohep 4500 IU\u002Fday.Ongoing treatment for malignancy.Known coagulation disorder.\n* Platelet count \\\u003C150 x 10⁹\n* PK-INR \\>1.2.\n* Hb \\\u003C120 g\u002FL.\n* APTT \\>42s.\n* Preoperative impaired facial nerve function on the affected side (Sunnybrook Facial Grading System score \\\u003C90).\n* Supplementary postoperative treatment such as radiotherapy or extended surgery.","ALL","18 Years",{"count":20,"type":21},600,"ESTIMATED","INTERVENTIONAL",[24],"NA","The purpose of this study The purpose of this study is to find out if it is safe to perform surgery on the parotid gland (the large salivary gland in front of the ear) without using a wound drain. A wound drain is a small plastic tube used to remove excess fluid from the surgical site after the operation. Currently, using a drain is the standard practice in Sweden, which often means patients must stay in hospital overnight. Researchers want to see if skipping the drain is just as safe and if it could allow more patients to return home on the same day as their surgery.\n\nWhat happens during the study\n\nParticipants in this study will be randomly assigned to one of two groups during their surgery:\n\nGroup 1: Will receive the standard treatment with a wound drain.\n\nGroup 2: Will have the surgery performed without a wound drain.\n\nApart from the use of a drain, all participants will receive the same surgical care. After the operation, researchers will monitor the healing process. Participants will be asked to fill out questionnaires about their health and any symptoms at one week and six months after their surgery.\n\nThe goal of the study The main goal is to compare the safety of the two methods. Researchers will look at whether there is any difference in the number of complications, such as fluid build-up (seroma), bleeding, or infections, between those who had a drain and those who did not. The study also aims to evaluate if avoiding a drain improves the patient's quality of life and if it is a more cost-effective approach for the healthcare system.",[27,28,29],"Parotid Neoplasms","Post-operative Complications","Seroma as Procedural Complication",[31,32,33,34,35,36,37,38,39,40],"Parotidectomy","Surgical drainage","Wound drains","Postoperative complications","Seroma","Hematoma","Randomised controlled trial","Non-inferiority","Salivary gland surgery","Quality of life","RECRUITING","2026-06-02",{"date":44,"type":45},"2026-06-04","ACTUAL",{"date":47,"type":45},"2026-05-06",{"date":49,"type":21},"2032-12",{"name":51,"class":52},"Uppsala University Hospital","OTHER",3,{"id":55,"slug":56,"hasResults":11,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":59,"eligibilityCriteria":60,"healthyVolunteers":11,"sex":17,"minAge":61,"maxAge":4,"enrollmentInfo":62,"targetDuration":4,"studyType":64,"phases":4,"briefSummary":65,"conditions":66,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":53},"100616051","vascular-events-in-noncardiac-surgery-patients-cohort-evaluation-study-2-100616051","NCT07300579","Vascular Events in Noncardiac Surgery Patients Cohort Evaluation Study 2","VISION-2","Inclusion Criteria:\n\n1. age ≥65 years;\n2. underwent non-cardiac surgery with general, neuraxial, local, or regional anesthesia; and\n3. expected length of hospital stay of 3 or more days\n\nExclusion Criteria:\n\n1. hearing aid(s) or cochlear implant(s) in left ear;\n2. pacemaker\u002Fimplantable cardioverter-defibrillator (ICD);\n3. externally programmable cerebrospinal fluid shunt;\n4. deep brain stimulator;\n5. intolerance\u002Fallergy to adhesive;\n6. history of dementia, or;\n7. previous enrollment in the VISION-2 Study","65 Years",{"count":63,"type":21},20000,"OBSERVATIONAL","VISION-2 is an international, multi-site, prospective observational cohort study of 20,000 patients undergoing noncardiac surgery. Continuous biometric data will be blindly collected for the first 30 postoperative days, in hospital and at home, using Vitaliti™. Following study enrollment and baseline data collection, follow up visits will occur in-hospital, at 30-days, and 1-year post-operatively.\n\nVISION-2 has 3 primary objectives, among participants who underwent noncardiac surgery, the investigators will: 1) determine the pattern and frequency of physiological precursors (i.e., biophysical signals) to MINS, BIMS, sepsis, and infection without sepsis; 2) build prediction models from these biophysical signals and their extracted features through supervised machine learning, for the prediction and early detection of those complications; and 3) build a biobank for evaluation of novel biomarkers.",[67,68,69,70,28],"Myocardial Injury After Noncardiac Surgery (MINS)","Bleeding Independently Associated With Mortality After Noncardiac Surgery (BIMS)","Sepsis","Infection Without Sepsis","NOT_YET_RECRUITING","2026-04-09",{"date":74,"type":45},"2026-04-14",{"date":76,"type":21},"2026-06",{"date":78,"type":21},"2032-06",{"name":80,"class":52},"Hamilton Health Sciences Corporation",{"id":82,"slug":83,"hasResults":11,"nctId":84,"briefTitle":85,"officialTitle":86,"acronym":87,"eligibilityCriteria":88,"healthyVolunteers":11,"sex":17,"minAge":89,"maxAge":4,"enrollmentInfo":90,"targetDuration":4,"studyType":22,"phases":92,"briefSummary":93,"conditions":94,"keywords":100,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":118},"100622551","continuous-vital-sign-monitoring-versus-routine-spot-checks-in-patients-after-non-cardiac-surgery-100622551","NCT07385092","Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery","The Effect of Continuous Monitoring Versus Routine Spot-checks on Altered Vital Signs in Patients Recovering From Non-cardiac Surgery on Normal Wards: the \"COME ON, NOW!\" Trial","COME ON NOW","Inclusion Criteria:\n\nConsenting patients ≥45 years scheduled for elective non-cardiac (abdominal and thoracic) surgery with planned postoperative admission to a normal ward after an overnight stay in an advanced post-anesthesia care unit.\n\nExclusion Criteria:\n\n* Emergency surgery\n* Pregnancy\n* Impossibility to perform continuous monitoring with the Radius VSM sensor (Masimo, Irvine, CA)\n* Atrial fibrillation\n* Patients designated Do Not Resuscitate, or are receiving end-of-life care","45 Years",{"count":91,"type":21},264,[24],"The \"COME ON, NOW!\" trial is a randomized, single-center trial in patients recovering from non-cardiac surgery on normal wards investigating whether continuous vital sign monitoring - compared to routine spot-checks by nurses - reduces the total duration of abnormal vital signs per hour during the first 48 hours after admission to the normal ward.",[95,96,97,98,99],"Vital Sign Monitoring","Post Operative Complications","Non-cardiac Surgery","RCT","Anesthesiology",[101,102,103,104,105,106,107,108],"continuous vital signs","vital signs","vital sign monitoring","post-operative care","anesthesiology","anesthesia","hypotension","post-operative complications","2026-02-27",{"date":111,"type":45},"2026-03-02",{"date":113,"type":45},"2026-02-24",{"date":115,"type":21},"2026-12-31",{"name":117,"class":52},"Universitätsklinikum Hamburg-Eppendorf",1,{"id":120,"slug":121,"hasResults":11,"nctId":122,"briefTitle":123,"officialTitle":124,"acronym":125,"eligibilityCriteria":126,"healthyVolunteers":127,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":128,"targetDuration":4,"studyType":22,"phases":130,"briefSummary":131,"conditions":132,"keywords":143,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":148,"lastUpdatePostDateStruct":149,"startDateStruct":151,"completionDateStruct":153,"leadSponsor":155,"locationsCount":157},"100562499","prevention-of-edema-after-coronary-artery-bypass-graft-by-customized-pressure-guided-elastic-bandages-100562499","NCT06603961","Prevention of Edema After Coronary Artery Bypass Graft by Customized Pressure-guided Elastic Bandages","Efficacy of Customized Pressure-Guided Elastic Bandages in Preventing Postoperative Edema and Complications in Coronary Artery Bypass Graft (CABG) Patients: A Comparative Study of Compression Therapy and Standard Post-CABG Care.","PEACCE","Inclusion Criteria:\n\n1. All patients scheduled for elective coronary artery bypass grafting (CABG) surgery with saphenous vein harvesting from the leg at Siriraj Hospital.\n2. Patients aged 18 years and older undergoing CABG surgery with saphenous vein harvesting from the leg at Siriraj Hospital, who willingly consent to participate in the study.\n\nExclusion Criteria:\n\n1. Patients with an Ankle-brachial pressure index (ABI) \\\u003C 0.8\n2. Patients with severe leg swelling (pitting edema of grade 3 or higher) or with pre-existing or post-operative heart failure that remains uncontrolled despite diuretic therapy.\n3. Patients with occlusive peripheral arterial disease (PAD) or chronic venous insufficiency (CEAP 2s), characterized by significant venous stasis, leg pain, varicose veins, or lymphadenopathy.",true,{"count":129,"type":21},106,[24],"The study aimed to assess the efficacy of customized pressure-guided elastic bandages (CPG-EB) in preventing postoperative edema and complications in Coronary Artery Bypass Graft (CABG) patients. While compression therapy, like compressive stockings, has benefits in preventing edema, concerns about affordability persist. CPG-EB provides optimal sub-bandage pressure, proven effective in venous leg ulcers. Implementing CPG-EB post-CABG could enhance venous blood flow, reducing complications and improving outcomes. Patients were divided into two groups: one with CPG-EB and the other standard post-CABG care. Data collected at 1, 2, and 6 weeks post-surgery assessed swelling and wound complications. Comparative analysis used standardized criteria.",[133,134,135,136,137,138,139,140,141,96,142],"Limb Edema","Surgical Site Infections","Leg Swelling","Compression Bandages","Coronary Artery Bypass Graft","CABG","Saphenectomy","Saphenous Vein","Delayed Wound Healing","Post Operative Surgical Site Infection",[144,145,146,138,147],"compression bandages","compression therapy","customized pressure-guided elastic bandages","coronary arterial bypass graft","2026-02-06",{"date":150,"type":45},"2026-02-09",{"date":152,"type":45},"2025-01-19",{"date":154,"type":21},"2026-05-31",{"name":156,"class":52},"Siriraj Hospital",2,{"id":159,"slug":160,"hasResults":11,"nctId":161,"briefTitle":162,"officialTitle":163,"acronym":4,"eligibilityCriteria":164,"healthyVolunteers":11,"sex":17,"minAge":61,"maxAge":4,"enrollmentInfo":165,"targetDuration":4,"studyType":64,"phases":4,"briefSummary":167,"conditions":168,"keywords":177,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":186,"lastUpdatePostDateStruct":187,"startDateStruct":189,"completionDateStruct":191,"leadSponsor":193,"locationsCount":118},"100592034","frailty-and-muscle-strength-tests-in-older-adults-undergoing-major-surgery-100592034","NCT06988176","Frailty and Muscle Strength Tests in Older Adults Undergoing Major Surgery","Feasibility and Correlation of Functional Muscle Strength Tests and Objective Frailty Measures With Clinical Frailty Scale in Patients Undergoing Major Surgery","Inclusion Criteria:\n\nParticipants may be eligible for this study if they meet the following conditions:\n\n* Age 65 years or older.\n* Scheduled for elective (planned, non-emergency) major abdominal surgery, including colorectal, hepatobiliary, gynecologic, or urologic procedures.\n* Able to attend a routine preoperative evaluation visit.\n* Able and willing to complete brief assessments for muscle strength, walking, breathing strength, memory, and nutrition.\n\nExclusion Criteria:\n\nParticipants will not be eligible for the study if they have any of the following conditions:\n\n* Surgery is an emergency procedure.\n* Unable to walk independently (for example, dependent on a wheelchair or bed-bound).\n* Significant cognitive impairment that prevents understanding or completing study tests.",{"count":166,"type":21},100,"The goal of this observational study is to learn if simple tests for frailty and muscle strength can help predict which older adults (age 65 and older) are at higher risk for problems after major abdominal surgery.\n\nThe main questions it aims to answer are:\n\n* Do measures of frailty and muscle strength, taken before surgery, predict complications after surgery?\n* Can these tests be easily done during a routine pre-surgical visit?\n\nParticipants will:\n\n* Complete brief tests measuring muscle strength, breathing strength, physical function, nutrition status, body composition, and memory during a regular pre-surgical clinic appointment.\n* Allow researchers to review their medical records 30 and 90 days after surgery to identify any complications or health problems.",[169,170,171,172,96,173,174,175,176],"Frailty","Sarcopenia","Sarcopenia in Elderly","Muscle Strength","Nutrition Assessment","Risk Assessment","Elderly (People Aged 65 or More)","Hand Strength",[169,178,179,180,176,181,182,174,173,183,184,185],"sarcopenia","elective abdominal surgery","Muscle strength","Inspiratory muscle strength","Post operative complications","Elderly patients","Cognitive Function","Physical functional performance","2026-01-27",{"date":188,"type":45},"2026-01-28",{"date":190,"type":45},"2025-06-19",{"date":192,"type":21},"2026-08",{"name":194,"class":52},"University of North Carolina, Chapel Hill",{"id":196,"slug":197,"hasResults":11,"nctId":198,"briefTitle":199,"officialTitle":200,"acronym":4,"eligibilityCriteria":201,"healthyVolunteers":11,"sex":17,"minAge":202,"maxAge":4,"enrollmentInfo":203,"targetDuration":4,"studyType":22,"phases":205,"briefSummary":206,"conditions":207,"keywords":214,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":224,"lastUpdatePostDateStruct":225,"startDateStruct":227,"completionDateStruct":228,"leadSponsor":230,"locationsCount":157},"100561028","enhanced-vitals-monitoring-after-major-surgery-trial-100561028","NCT06584825","Enhanced Vitals Monitoring After Major Surgery Trial","The Impact of Enhanced Postoperative Vitals Monitoring In-hospital and at Home vs. Standard Care After Inpatient Abdominal and Vascular Surgery: A Pilot Two-centre Randomized Controlled Study","Inclusion Criteria:\n\n1. Undergoing inpatient major abdominal (general surgery, urology, or gynecology) or vascular surgery at St. Paul's Hospital (SPH) and Mount Saint Joseph (MSJ) Hospital\n2. Length of stay of at least 48 hours (planned by the clinical team, or by the Canadian Institute of Health Information Discharge Abstract Database Expected Length of Stay (ELOS) for the surgical case mix group\n3. Self-reported fluency in reading and speaking in English for patient or home caregiver\n4. Living within British Columbia, Canada and in an area that is covered by Bell cellular network (the Cloud DX Inc. device has cellular Long Term Evolution (LTE) using the Bell network).\n\nExclusion Criteria:\n\n1. Patient refusal\n2. Transplant surgery, since these patients have a unique set of considerations and postoperative course.\n3. Inability to communicate with research personnel, perform self-monitoring of vital signs, or complete study surveys due to cognitive, language, visual, or hearing barriers\n4. Lack of capacity to consent to the study (including under the active influence of sedative medication or having received general anesthetic within the past 24 hours)\n5. Unable to use (or does not have a caregiver who can help put on\u002Ftake off) study monitoring device at home\n6. Preoperatively known planned discharge to a nursing home or rehabilitation facility\n7. Patient with known allergic reactions to any part material of the device\n8. Unable to monitor blood pressure accurately noninvasively using arm blood pressure cuffs, such as due to underlying vascular anatomy or non-pulsatile blood flow physiology\n9. Unlikely to be able to return the home monitoring kit (no fixed address, living too far away from site, etc.)","19 Years",{"count":204,"type":21},110,[24],"The aim of this clinical trial is to examine the feasibility of an enhanced vital sign monitoring solution in-hospital and at-home. This study includes adult patients undergoing inpatient major vascular or abdominal surgery. Researchers will compare the enhanced vitals monitoring group to the standard of care group to see if it may change post-operative management and outcomes. The primary question it aims to answer is if enhanced monitoring of surgical patient vitals can increase the number of days at home alive in the first 30 days after surgery. Participants in the intervention group will test two vitals monitoring devices, one in the hospital and one at home. They will also be asked to complete several questionnaires and a follow up phone call.",[208,96,209,210,211,212,213],"Surgery","Quality of Recovery","General Surgery","Vascular Surgery","Urology","Gynecology",[215,216,217,218,219,220,221,222,223],"Days alive and at home","DAH30","Quality of Recovery 15","Pilot Randomized Controlled Trial","vitals","blood pressure","heart rate","oxygen saturation","device","2025-11-17",{"date":226,"type":45},"2025-11-21",{"date":224,"type":45},{"date":229,"type":21},"2027-12-31",{"name":231,"class":52},"University of British Columbia",{"id":233,"slug":234,"hasResults":11,"nctId":235,"briefTitle":236,"officialTitle":236,"acronym":4,"eligibilityCriteria":237,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":238,"targetDuration":4,"studyType":22,"phases":239,"briefSummary":240,"conditions":241,"keywords":246,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":249,"lastUpdatePostDateStruct":250,"startDateStruct":252,"completionDateStruct":254,"leadSponsor":256,"locationsCount":4},"100600887","evaluation-of-cranial-flap-fixation-with-montage-flowable-settable-bone-paste-100600887","NCT07103330","Evaluation of Cranial Flap Fixation With Montage Flowable Settable Bone Paste","Inclusion Criteria:\n\n1. Male or female \\> 18 years of age\n2. Undergoing a cranial procedure in supratentorial location\n3. Width of craniotomy kerf line \\\u003C3mm for than 75% of the bone flap border\n\nExclusion Criteria:\n\n1. Subject requires a procedure involving a translabyrinthine, transsphenoidal, transoral approach, or any procedure that penetrates the air sinus or mastoid air cells.\n2. Subject has clinically significant hydrocephalus or clinical evidence of altered CSF dynamics.\n3. Subject has undergone a previous, open intracranial neurosurgical procedure in the same anatomical location. (Note: stereotactic biopsy was not exclusionary).\n4. Subject requires a craniectomy (the bone flap is not replaced during the current surgery).\n5. Subject had radiation treatment to the surgical site, or standard fractionated radiation therapy was planned post index-procedure. (Note: stereotactic radiosurgery prior to the planned index procedure was not an exclusion criterion.)\n6. Subject requires a craniotomy across the sinus for which Montage Flowable is applied adjacent to or within the sinus to fixate the cranial flap.\n7. Subject has a condition with anticipated survival shorter than six months.\n8. Subject has undergone chemotherapy treatment, excluding hormonal therapy, within three weeks prior to the planned index procedure, or use of intracavitary chemotherapy wafer (BCNU) was planned, or chemotherapy treatment was planned within two weeks after the index procedure was performed.\n9. Standard use of peri-operative steroids (i.e., corticosteroids) is permitted. Chronic steroid use (defined as daily use of corticosteroids for ≥ 8 weeks) for the purposes of reducing the side effects of chemotherapy and\u002For radiation therapy for cancer is not exclusionary unless the patient is deemed by the investigator to be suffering from steroid toxicity (i.e., Cushing's syndrome) manifested by symptoms and signs such as thin skin, striae, easy bruising, muscle atrophy, upper body obesity, severe fatigue, etc. Use of corticosteroids on a chronic basis (as defined previously) for purposes other than decreasing the symptoms of systemic chemotherapy is exclusionary unless those steroids were discontinued 4 weeks prior to the planned index procedure.\n10. Subject receives warfarin, heparin, other anticoagulant agents on a daily basis and pre-surgical, standard of care drug wash-out did not occur.\n11. Subject is pregnant, breast-feeding, or intended to become pregnant during the course of the study.",{"count":166,"type":21},[24],"Montage Flowable Settable Bone Paste is a self-setting calcium phosphate cement indicated for use in the repair of neurosurgical burr holes, contiguous craniotomy cuts and other cranial defects with a surface area no larger than 25cm2. It is also intended to be used for the fixation of cranial bone flaps following craniotomy. The MONTAGE Flowable device comprises two separate components of paste-like consistency containing granular calcium phosphate, calcium stearate, vitamin E acetate, a triglyceride, polyalcohols and a mixture of a lactide-diester and polyester-based polymers. When mixed together in the applicator tip, the components of the MONTAGE Flowable device form a cohesive paste-like material that adheres to the bone surface and remains in place following application. The resulting hardened, resorbable material is primarily calcium phosphate. The components must be mixed immediately prior to use.",[242,28,243,244,245],"Cranial Bone","Cranial Fixation","Cranioplasty","Adhesive Bone Cement",[244,247,248],"Settable bone paste","Adhesive cranial cement","2025-07-29",{"date":251,"type":45},"2025-08-05",{"date":253,"type":21},"2026-03",{"date":255,"type":21},"2027-12",{"name":257,"class":258},"Abyrx, Inc.","INDUSTRY",{"id":260,"slug":261,"hasResults":11,"nctId":262,"briefTitle":263,"officialTitle":264,"acronym":265,"eligibilityCriteria":266,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":267,"targetDuration":4,"studyType":22,"phases":269,"briefSummary":270,"conditions":271,"keywords":272,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":276,"lastUpdatePostDateStruct":277,"startDateStruct":279,"completionDateStruct":281,"leadSponsor":283,"locationsCount":285},"100587766","reducing-deaths-after-surgery-in-low--and-middle-income-countries-a-pilot-cluster-randomised-trial-100587766","NCT06932653","Reducing Deaths After Surgery in Low- and Middle-income Countries: A Pilot Cluster Randomised Trial","SurgPASS: Reducing Deaths After Surgery in Low- and Middle-income Countries: A Pilot Cluster Randomised Trial","SurgPASS","Inclusion criteria:\n\n* Patients undergoing emergency major abdominal surgery (i.e., midline or non-midline) with an incision greater than or equal to 5cm\n* Patient must not be pregnant\n* Adults only (greater than or equal to 18 years old)\n\nExclusion criteria:\n\n* Minimally invasive surgery\n* Surgery for appendicitis",{"count":268,"type":21},300,[24],"SurgPASS is a pilot randomised cluster trial utilising a pre-operative checklist with the aim of reducing deaths after surgery. If SurgPASS is successful, the intervention will be implemented in a separate full-scale cluster randomised trial.",[28],[273,274,275],"pilot","cluster","surgical safety","2025-04-10",{"date":278,"type":45},"2025-04-17",{"date":280,"type":21},"2025-06-01",{"date":282,"type":21},"2026-01-31",{"name":284,"class":52},"University of Birmingham",5,{"id":287,"slug":288,"hasResults":11,"nctId":289,"briefTitle":290,"officialTitle":290,"acronym":291,"eligibilityCriteria":292,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":293,"targetDuration":295,"studyType":64,"phases":4,"briefSummary":296,"conditions":297,"keywords":4,"overallStatus":41,"whyStopped":4,"lastUpdateSubmitDate":312,"lastUpdatePostDateStruct":313,"startDateStruct":315,"completionDateStruct":317,"leadSponsor":319,"locationsCount":118},"100335153","web-based-international-register-of-emergency-surgery-and-trauma-100335153","NCT03643718","Web-based International Register of Emergency Surgery and Trauma","WIRES-T","Inclusion Criteria:\n\n* Patients affected by an acute surgical disease\n* Patients with indication to be referred to the emergency surgeon attention\n* Patients to be operated or to be treated with non-operative approach without surgical intervention\n\nExclusion Criteria:\n\n* Patients not affected by an acute surgical disease\n* Patients without indication to be referred to the emergency surgeon attention",{"count":294,"type":21},10000,"2 Weeks","The WIRES-T project (Web-based International Registry of Emergency General Surgery and Trauma) has been set up to allow to all the EGS (Emergency General Surgery) and Trauma surgeons to register their activity and to obtain a worldwide register of traumatic and non traumatic surgical emergencies. This will give the opportunity to evaluate results on a macro-data basis and to give index allowing stratifying, evaluating and improving the outcomes.",[298,299,300,28,301,302,303,304,305,306,307,308,309,310,311],"Acute Appendicitis","Acute Cholecystitis","Acute Diverticulitis","Acute Pancreatitis","Perforated Gastro-duodenal Ulcers","Adhesive Small Bowell Occlusion","Colonic Neoplastic Emergencies","Gynecological Emergencies","Vascular Emergencies","Intestinal Ischemia","Abdominal Wall Hernia","Foreign Bodies","Caustic Ingestion","Trauma","2020-07-10",{"date":314,"type":45},"2020-07-14",{"date":316,"type":21},"2020-07",{"date":318,"type":21},"2030-09",{"name":320,"class":52},"A.O. Ospedale Papa Giovanni XXIII","Post-Operative Complications"]